2023/02 - Impact of ferumoxytol vs galolinium on 4D flow cardiovascular magnetic resonance measurements in small children with congenital heart disease [Journal Club]-February Journal Club

Video Transcription

Video Summary

The session opened with SCMR journal club logistics, including recording access, CME registration via QR code, and instructions for audience questions through Zoom chat. The featured paper was <strong>“Impact of Ferumoxytol versus Gadolinium on 4D-Flow Cardiovascular MR Measurements in Small Children with Congenital Heart Disease.”</strong>

Dr. Sarah Kollar presented a retrospective single-center study of <strong>44 children under 20 kg</strong> who underwent both <strong>4D-flow CMR</strong> and standard <strong>2D phase-contrast flow measurements</strong> at 1.5T. The study compared <strong>ferumoxytol-enhanced</strong> versus <strong>gadolinium-enhanced</strong> imaging. Ferumoxytol, an IV iron formulation used off-label as an MR contrast agent, has a much longer intravascular half-life than gadolinium and can provide stronger blood-pool signal, potentially improving flow quantification in small vessels.

Key findings showed that <strong>ferumoxytol-enhanced 4D-flow had better agreement with 2D flow measurements than gadolinium</strong>, especially in <strong>single-ventricle patients</strong>, <strong>low-flow vessels</strong>, and <strong>small-caliber pulmonary veins</strong>. Ferumoxytol also produced <strong>higher contrast-to-noise ratio (CNR)</strong> even with smaller spatial resolution. Interobserver and intraobserver agreement were excellent. No contrast reactions were observed in this cohort.

During discussion, the panel reviewed ferumoxytol’s clinical background, off-label diagnostic use, infusion practices, safety considerations, impact on later MR sequences, and cost. The speakers emphasized that ferumoxytol may be particularly valuable in pediatric and congenital heart disease imaging where high-quality visualization of tiny vessels and accurate flow quantification are critical for management and surgical planning.

Keywords

ferumoxytol

gadolinium

4D-flow CMR

congenital heart disease

pediatric imaging

flow quantification

contrast-to-noise ratio

single-ventricle patients

phase-contrast MRI

cardiovascular MR